Solu-medrol Injection, Powder, For Solution
Product Images NDC 0009-0039

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Solu-medrol (NDC 0009-0039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Solu Medrol 01)

FDA Label Image

Figure (Solu Medrol 02)

FDA Label Image

Logo (Solu Medrol 03)

Logo (Solu Medrol 03)
This is a label of a pharmaceutical product called "Inectables". It is distributed by Pharmacia & Upjohn Co, which is a division of Pfizer Inc, located in New York, NY 10017.*
FDA Label Image

Principal Display Panel (500 mg Vial Label)

Principal Display Panel (500 mg Vial Label)
This is a description of a medication with instructions on its use and storage. It is intended for intramuscular or intravenous injection using a multi-dose vial. The medication is stored at a controlled room temperature of 20° to 25°C (68° to 77°F) and protected from light. The medication is reconstituted with 8 mL of Bacteriostatic Water for injection and contains 500 mg per vial of methylprednisolone sodium succinate for injection USP. The package does not contain a diluent. The dosage and use instructions are found in the accompanying prescribing information. This medication is distributed by Pharmacia & Upjohn Co. Division of Pfizer Inc, NY, NY 10017 and is available by prescription only.*
FDA Label Image

Principal Display Panel (500 mg Vial Carton)

Principal Display Panel (500 mg Vial Carton)
This is a description of Solu-Medrol (methylprednisolone sodium succinate for injection) in a 500mg mult-dose vial for intramuscular or intravenous use only. The package does not contain diluent, which is recommended as bacteriostatic water for injection containing benzyl alcohol as a preservative. The solution should be stored at controlled room temperature between 20° to 25°C (68° to 77°F) and protected from light. The solution is to be reconstituted with 8mL of bacteriostatic water for injection with benzyl alcohol and used within 48 hours after mixing. The dosage and use information can be found in the accompanying prescribing information. The vial is distributed by Phamacia & Upjohn Co division of Prizer Inc, New York, NY 10017.*
FDA Label Image

Principal Display Panel (1 gram Vial Label)

Principal Display Panel (1 gram Vial Label)
Solu-Medrol is a medicine for intramuscular or intravenous use only. It should be stored at a controlled temperature of 20° to 25°C (68° to 77°F) and protected from light. To reconstitute, use Bacteriostatic Water for Injection with Benzyl Alcohol and maintain the solution at a controlled temperature of 20° to 25°C (68° to 77°F). The recommended diluent contains a preservative. The concentration is 62.5 mg per mL, and it is only valid for 48 hours after mixing. Unused portions must be discarded. For further instructions, refer to the prescribing information.*
FDA Label Image

Principal Display Panel (1 gram Vial Carton)

Principal Display Panel (1 gram Vial Carton)
This is a description of a drug called Solu-Medrol. It is provided in vials, each containing 1 gram of the active ingredient: methylprednisolone sodium succinate. It can be used for intramuscular or intravenous injection only, and requires reconstitution with bacteriostatic water for injection containing benzyl alcohol as a preservative. The vials are multi-dose and any unused portions should be discarded. The recommended storage temperature is 20° to 25°C. The instructions for use should be obtained from the accompanying prescribing information.*
FDA Label Image

Principal Display Panel (2 gram Vial Label)

Principal Display Panel (2 gram Vial Label)
This is medication information for Solu-Medrol, which contains methylprednisolone sodium succinate for injection. The medication is to be stored at 20° to 25°C (68° to 77°F) and protected from light. Instructions for reconstitution with Bacteriostatic Water for Injection are given, and the solution should be used within 48 hours of reconstitution. The medication is for intramuscular or intravenous use only and contains 2 grams of methylprednisolone per vial. Additional dosage and use information should be found in accompanying prescribing information.*
FDA Label Image

Principal Display Panel (2 gram Vial Carton)

Principal Display Panel (2 gram Vial Carton)
This is a description of a medication called Solu-Medrol, which comes in a single-use vial containing 2 grams of methylprednisolone sodium succinate for injection. The vial contains benzyl alcohol as a preservative and should be discarded if any portion goes unused. This medication is for intramuscular or intravenous use only and should be mixed only with the accompanied diluent. The packaged diluent contains benzyl alcohol as a preservative as well. It is distributed by Phamacia & Upon Co and should be stored at a controlled room temperature. The enclosed package also contains one 30 mL vial of Bacteriostatic Water for Injection with added preservative.*
FDA Label Image

Principal Display Panel (40 mg Vial Label)

FDA Label Image

Principal Display Panel (40 mg Vial Carton)

Principal Display Panel (40 mg Vial Carton)
Solu-Medrol is a medication for injection containing methylprednisolone sodium succinate, with a concentration of 40mg per vial. It is intended for intramuscular or intravenous use only and should be stored in a controlled room temperature of 20-25°C. The medication does not contain any preservatives and is suitable for vegetarians. The dosage should be determined by a healthcare professional. No other useful information is available as most text is not readable or appears to be garbled.*
FDA Label Image

Principal Display Panel (40 mg Vial Label)

Principal Display Panel (40 mg Vial Label)
This is a description of a medication named "SOLU-MEDROL". The medication should be protected from sunlight. The dosage and usage instructions are not available. Each milliliter of the medication contains 40mg of methylprednisolone sodium succinate. It is distributed by Pharmacia & Upjohn Co, which is a division of Pfizer Inc. The medication comes in a 40mg vial and is preservatives free. The trademark "novaplus" is mentioned at the end.*
FDA Label Image

Principal Display Panel (40 mg Vial Carton)

Principal Display Panel (40 mg Vial Carton)
The text appears to be a description of a medical product called "Methylprednisolone Sodium Succinate for Injection, USP" which is available in 40mg per vial and comes with a Preservative-Free 25-1ml Ad-0¥al®. It provides instructions for use, mentions the appropriate storage temperature, and cautions to discard unused portions. The text also contains some illegible characters and random letters, making it difficult to understand in certain parts.*
FDA Label Image

Principal Display Panel (125 mg Vial Label)

Principal Display Panel (125 mg Vial Label)
This is a single-dose vial of Solu-Medrol (methylprednisolone sodium succinate for injection, USP) with a dosage of 125 mg per vial. The medication is intended for intramuscular or intravenous use only and any unused portion of the medication should be discarded. The vial should be protected from light. Detailed dosage and usage instructions are provided in the accompanying prescribing information. The medication is distributed by Pharmacia & Upjohn Co division of Pfizer Inc, located in NY, NY. The NDC number for this medication is 0009-0047-25. Preservatives are not included in the medication.*
FDA Label Image

Principal Display Panel (125 mg Vial Carton)

Principal Display Panel (125 mg Vial Carton)
Solu-Medrol® is a medication used for intravenous injection. It contains 125 mg of methylprednisolone sodium succinate per vial and is preservative-free. It is important to store the medication at controlled room temperature between 20-25°C (68-77°F). The text also includes dosage instructions and information about the components of the medication, but it is difficult to read due to errors.*
FDA Label Image

Principal Display Panel (125 mg Vial Label)

Principal Display Panel (125 mg Vial Label)
SOLU-MEDROL is a medication that contains methylprednisolone and is distributed by Pharmacia & Upjohn Co, a division of Pfizer Inc. Each 2mL (when mixed) of the medication contains 125mg of methylprednisolone sodium succinate equivalent. The medication is in a yophilzed container and should be protected from light. The prescribing information should be consulted before use. Novaplus is a registered trademark of Vizient, Inc. The medication is provided in a single-dose vial of 125mg. Any unused portion of the medication in the Preservative-Free container should be discarded. The text also contains several random characters, which should be ignored.*
FDA Label Image

Principal Display Panel (125 mg Vial Carton)

Principal Display Panel (125 mg Vial Carton)
This is a product description for Solu-Medrol® containing Methylprednisolone Sodium Succinate for injection, used to reduce inflammation. Each vial contains 125mg of the medication, and this product has a total of 2501 NDCO0S.009.27. The medication is preservative-free and should be stored at controlled room temperature between 20-25°C (68-77°F) as per USPL guidelines. The text includes directions for administration and storage, including removing the plastic cap and shaking the solution before use.*
FDA Label Image

Principal Display Panel (500 mg Vial Label)

Principal Display Panel (500 mg Vial Label)
This is a medication with the brand name Solu-Medrol, which is only for intramuscular or intravenous use, delivered in a single-dose vial. Its National Drug Code is 0009-0003-02. The solution should be stored at controlled room temperature between 20-25°C (68-77°F) and protected from light. After mixing, the medication is only safe to use for 48 hours. Once mixed with the diluent, it produces a concentration of 125 mg per mL. This medication is distributed by Pharmacia & Upjohn Co, a subsidiary of Pfizer Inc. It is prescription-only and does not contain preservatives.*
FDA Label Image

Principal Display Panel (500 mg Vial Carton)

Principal Display Panel (500 mg Vial Carton)
This is a description of Solu-Medrol, a prescription medication used for intramuscular or intravenous administration only. It comes in single-dose vials of 500mg of methylprednisolone sodium succinate. The solution should be discarded if unused and is preservative-free. Directions for using the Act-0-Vial® system are provided with the medication. Once reconstructed with 4ml of the diluent, the resulting concentration is 125mg per mL. The medication must be stored at a controlled temperature of 20° to 25°C (68° to 77°F) and must be used within 48 hours after reconstitution. The medication is distributed by Pharmacia & Upjohn Co, a division of Pfizer Inc, in New York.*
FDA Label Image

Principal Display Panel (1 gram Vial Label)

Principal Display Panel (1 gram Vial Label)
This is the information given on a Single-Dose Vial of Solu-Medrol (methylprednisolone sodium succinate for injection, USP) for Intramuscular or Intravenous use. The vial contains 1 gram and is to be reconstituted with 8 mL of Diluent, resulting in a concentration of 125 mg per mL. The solution must be stored at controlled room temperature of 20° to 25°C (68° to 77°F) and protected from light. Unused portion should be discarded, and the solution should be used within 48 hours after mixing. For dosage and use, consult the accompanying prescribing information. This product is manufactured and sold by Pharmacia & Upjohn Co., a subsidiary of Pfizer Inc., and it is only available by prescription.*
FDA Label Image

Principal Display Panel (1 gram Vial Carton)

Principal Display Panel (1 gram Vial Carton)
This is a pharmaceutical product called Solu-Medrol. It is in a single-dose vial that contains 1 gram of methylprednisolone sodium succinate for intramuscular or intravenous use. The product is preservative-free and the unused portion should be discarded. The medication is stored at a controlled temperature of 20°C to 25°C. Instructions are provided for using the Act-0-Vial system to administer the medication. There is also information on the label about the distributor of the product, Phamacia & Upjohn Co, a division of Pfizer Inc.*
FDA Label Image

Principal Display Panel (2 grams Vial Label)

Principal Display Panel (2 grams Vial Label)
This is a description of the drug Solu-Medrol, which is for intramuscular or intravenous use only. It should be stored at a controlled room temperature between 20 to 26°C and protected from light. To be used, it must be reconstituted with 30 mL of Bacteriosati Water for Injection with Benzyi Alcohol and should be kept at a controlled temperature between 20 to 26°C and used within 48 hours after mixing. It's distributed by Phamaca & Ugiohn Co Division ofPicer n, 1Y NY 10017. The drug contains methylprednisolone sodium succinate equivalent to 2 grams of mettyipredrisolone in 30.6 mL (65.4mg per mL) once reconstituted. The package doesn't contain diluent, but recommended diluent (Bacteriostatic Water for Injection) contains Benzy! Alcohol as a preservative. The Single-Dose Vial should be discarded if the unused portion remains.*
FDA Label Image

Principal Display Panel (2 grams Vial Carton)

Principal Display Panel (2 grams Vial Carton)
This appears to be a product description for Solu-Medrol, a medication used for intramuscular or intravenous use. The medication comes in a single-dose vial, containing 2 grams of methylprednisolone sodium succinate for injection, which should be discarded if unused. Dilution with bacteriostatic water is recommended, as the package contains benzyl alcohol as a preservative. The text also includes some illegible characters, making some words and phrases difficult to read and understand completely.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.